Monday, August 25, 2025

HIV research cuts impact progress on work to end epidemic : NPR

Thank you for reading this post.  This blog is published by our YouTube Channel, BRO.  If you are looking for reliable, no B.S. ways to supplement your retirement income each month, check out the channel's course on Udemy.  Remote Jobs for Retirees and Expats. 

How will the Trump administration’s cuts to HIV analysis impression the progress that is been made in direction of ending the epidemic within the U.S.?



Little Huang, Host:

Throughout his first time period, President Trump laid out a daring proposal throughout a State of the Union deal with.

(SOUNDBITE OF ARCHIVED RECORDING)

travel medical insurance based on age and cost of trip

PRESIDENT DONALD TRUMP: My price range will ask Democrats and Republicans to make the wanted dedication to get rid of the HIV epidemic in america inside 10 years. Now we have made unimaginable strides, unimaginable.

(APPLAUSE)

HUANG: The Trump administration’s objective of eliminating HIV within the U.S. led to a swell of analysis and funding to review the virus. However within the opening months of his second time period, the Trump administration slashed 1000’s of Public Well being jobs and gutted funding for scientific analysis, together with grants and funds for HIV and AIDS analysis. What does this imply for the way forward for HIV analysis within the U.S.? Dr. John Brooks is the previous chief medical officer to the CDC’s division of HIV prevention, and he joins me now. Dr. Brooks, welcome to ALL THINGS CONSIDERED.

JOHN BROOKS: Properly, Pien, thanks. It is a pleasure to be right here, and I respect your consideration to this concern.

HUANG: So initially, are you able to give us a way of the place HIV analysis stood earlier than these cuts?

BROOKS: Properly, you recognize, HIV analysis has been in place because the discovery of the virus as the reason for superior HIV illness, which we used to name AIDS. And it is, you recognize, made unimaginable strides. We at the moment are at a spot, resulting from constant funding by principally federal assist, that is found wonderful medicine that may assist us each deal with HIV to maintain an individual wholesome but additionally to forestall HIV.

HUANG: Have been there any therapies that we have been type of – you recognize, you are speaking about therapies which have been developed and are on the market working for individuals. Was there something additionally that was within the works that we’ve not fairly gotten to but?

travel medical insurance based on age and cost of trip

BROOKS: Yeah, so a few crucial issues. Initially, there was a decadeslong pursuit of an HIV vaccine, and that analysis, in addition to analysis for an HIV remedy, seems to have been canceled. That was principally analysis funded by the NIH. A vaccine could be unimaginable if we might have it – huge public well being impression, gigantic financial advantages, in addition to the scientific developments it would present and has supplied prior to now. Ditto for an HIV remedy. Secondly, the way in which that we can provide individuals drugs, each to deal with their an infection and to guard individuals from getting contaminated, are advancing very quickly. A brand new drug, lenacapavir, has lately been authorized not just for treating but additionally for stopping HIV. And uniquely, it is easy to manage. It is about as straightforward to manage as a vaccine, and it may defend an individual for as much as six months.

HUANG: So decreasing or eliminating HIV requires a two-pronged method. There’s the prevention a part of it after which the remedy a part of it. And I am questioning the way you see these cuts impacting every of these approaches.

BROOKS: One of many issues that worries me is that the main focus of the present administration with regard to HIV – which by the way is included as a brand new a part of the Administration for a Wholesome America – that HIV bureau or division, no matter it is finally named, appears extremely centered on simply remedy. However I believe these of us who work in infectious ailments know properly that remedy isn’t going to be the way in which you are going to get out of any epidemic. Prevention is an important element. And what we’re seeing now could be significantly round prevention analysis and prevention actions, an actual discount in what’s being completed.

HUANG: So given the place we’re, and that, you recognize, the truth that Trump’s initiative to get rid of HIV within the U.S. continues to be being funded, such as you mentioned, possibly beneath the brand new Administration for a Wholesome America, at the same time as different HIV analysis is being minimize, do you assume the U.S. can nonetheless attain this objective of eliminating HIV by 2030?

BROOKS: Properly, I am a born optimist, and I’m hopeful. However truthfully, I believe that with the cuts being made in analysis and, specifically, the exceptional and, in my view, draconian cuts being made to federal funding in HIV prevention, are going to result in a rise in new HIV infections nationally. Now we have made nice strides on this nation beneath the president’s first-term signature initiative to get rid of the HIV epidemic in America. Within the first 4 years that it was in impact, we have seen a 12% decline in new infections nationally and a 19% decline in deaths resulting from HIV.

HUANG: It feels like what you are saying, Dr. Brooks, is that present HIV sufferers will nonetheless be capable to entry remedy, however you are significantly anxious concerning the prevention a part of it, the prevention of recent individuals from getting HIV. Is that proper?

BROOKS: That is completely proper. You understand, PrEP, this medicine that’s given to forestall an infection – it stands for pre-exposure prophylaxis – has made terrific advances. There is a new drug that is on the market that you just solely should take twice a 12 months by injection that may be administered as simply as a vaccine. Nevertheless, the drug could also be accessible, and it could be very potent, however not all people has entry to it. To succeed in this drug and to get that safety, it is advisable remember that you’re in danger for HIV and be taught that you do not have HIV, so the drug can defend you. And then you definately want to have the ability to get to a spot that may administer it, you want to have the ability to afford it, and also you want to have the ability to keep engaged within the form of care that it is advisable administer the drug so long as you want it.

travel medical insurance based on age and cost of trip

HUANG: That is Dr. John Brooks, former chief medical officer to the CDC’s Division of HIV Prevention. Dr. Brooks, thanks for becoming a member of us.

BROOKS: Thanks very a lot. Take care.

Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.

Accuracy and availability of NPR transcripts could range. Transcript textual content could also be revised to right errors or match updates to audio. Audio on npr.org could also be edited after its unique broadcast or publication. The authoritative file of NPR’s programming is the audio file.

Related Articles

Latest Articles